Search
4 studies match these filters. Showing 1–4 of 4 studies
| Registration number | Study | Status | Phase | Enrolment | Sites / countries | Start year | Last updated | Actions |
|---|---|---|---|---|---|---|---|---|
| NCT06547489 | Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder The goal of this clinical trial is to learn if zelquistinel works to treat depression in adults. It will also learn about the safety of zelquistinel. The main questions it aims to answer are: Does zelquistinel reduce depression scores in participants compared to participants who take a placebo (a l… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 34 sites in total | Recruiting | Phase 2 | 164target | 34 / 1 | 2025 | Aug 3, 2026 | |
| NCT06847321 | Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease This study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental decline in the last year and who have P. gingivalis (Pg) infection. P. gingivalis infection has been linked to the development of dementia. LHP588 is designed to target the P.… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 38 sites in total · contact listed | Recruiting | Phase 2 | 300target | 38 / 1 | 2025 | Sep 15, 2026 | |
| NCT07609108 | Pridopidine Phase 3 Study in Huntington's Disease The goal of this clinical trial is to learn if pridopidine can slow the clinical decline of Huntington's Disease (HD) in adult participants. It will also inform about the safety of pridopidine. The main questions the study aims to answer are: Does pridopidine slow the overall worsening of HD over… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 66 sites in total · contact listed | Recruiting | Phase 3 | 400target | 66 / 12 | 2026 | Sep 17, 2026 | |
| NCT01574053 | Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 183 sites in total · contact listed | RecruitingNot verified since Feb 1, 2024 | 35,000target | 183 / 20 | 2012 | Feb 28, 2024 |